ARLINGTON, Va. — Data published today by the HDA Research Foundation reveal an estimated 93% of all U.S. pharmaceutical sales were completed through HDA-member traditional pharmaceutical distributors in 2019. As illustrated in the 91st Edition HDA Factbook, total distributor sales reached $519 billion. “Each year, the Factbook quantifies the role distributors play as the critical connection
ARLINGTON, Va. — The HDA Research Foundation announced Michael Conley, vice president and head, trade operations and analytics, Novartis Pharmaceuticals Corp., as chairman of its board of directors. Craig Cowman, executive vice president, global sourcing, Cardinal Health, is vice chairman. Conley, formerly the vice chairman for the foundation, assumes the role from Charles (Chip) Phillips,
ARLINGTON, Va. — The HDA Research Foundation honored three graduate students as the recipients of its second annual scholarship. “Our 2020 scholars demonstrate remarkable dedication to leadership and innovation as well as a desire to promote the greater good of their organization,” said Perry Fri, executive vice president and chief operating officer of the HDA
ARLINGTON, Va. — A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4%. “Specialty drugs account for nearly half of
ARLINGTON, Va. — In 2018, sales through pharmaceutical distributors increased by 6.7%, reaching $492.54 billion, according to a new report by the HDA Research Foundation. The 90th Edition HDA Factbook: The Facts, Figures and Trends in Healthcare (2019–2020) also notes that chain drug stores were the largest customer base for pharmaceutical wholesalers — accounting for
ARLINGTON, Va. — A new report published by the HDA Research Foundation concludes that federal proposals to permit the importation of prescription drugs into the U.S. fail to provide comprehensive guidance and funding to meet current federal safety and quality standards. As highlighted in the report, “The Risks and Realities of Commercial Drug Importation,” implementation
ARLINGTON, Va. — The Healthcare Distribution Alliance recognized AbbVie US; AmerisourceBergen Corporation; Genentech, a Member of the Roche Group; McKesson Corporation and Pfizer, Inc., with the 2019 Distribution Management Award (DMA) for the MediLedger Project, a blockchain-enabled traceability initiative. The companies were honored today at the HDA Distribution Management Conference and Expo in Palm Desert, Calif.
ARLINGTON, Va. — The HDA Research Foundation Thursday announced the selection of four HDA-member professionals as the inaugural recipients of its graduate-level scholarship program. The scholarship, developed as part of the organization’s mission to foster industry knowledge and established in conjunction with HDA’s Convene program, is available annually to graduate-level students working within HDA-member distributor and manufacturer companies.
ARLINGTON, Va. — Data published by the HDA Research Foundation reveal the changing market dynamics of the nearly $200 billion specialty pharmaceutical supply chain segment — and the important role HDA-member specialty pharmaceutical distributors play within it. The 2018 Specialty Pharmaceutical Distribution: Facts, Figures and Trends publication is based on an annual survey of HDA-member
ARLINGTON, Va. — The HDA Research Foundation is seeking to support the next generation of supply chain leaders through a new scholarship program. Created in conjunction with HDA’s professional development program, Convene, the HDA Research Foundation Scholarship is available biannually to graduate-level students currently working within HDA-member distributor and manufacturer companies. “The formation of a graduate-level
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) will convene pharmaceutical supply chain industry leaders at its Traceability Seminar, October 17 to 19 in Washington, D.C. The 2018 seminar will educate attendees about where the pharmaceutical supply chain is in relation to achieving full implementation of the Drug Supply Chain Security Act (DSCSA) in 2023; what to expect
COLORADO SPRINGS, Colo. — The HDA Research Foundation, the non-profit organization of the Healthcare Distribution Alliance (HDA), recognized Michael Conley of Novartis Pharmaceuticals Corp. with the 2018 Nexus Award for Lifetime Achievement at the HDA Business and Leadership Conference in Colorado Springs. The award is made possible through the support of Genentech, A Member of the
ARLINGTON, Va. — Chain drug stores remain the largest customer segment for U.S. pharmaceutical distributors, according to the HDA Research Foundation. The 88th Edition HDA Factbook (2017‐2018) said chain drug retailers accounted for nearly 30% of all sales to drug distributors last year. Dollar sales to independent pharmacies dipped 1.1%, while sales to hospitals and
ARLINGTON, Va. — The Healthcare Distribution Alliance (HDA) is conducting a webinar to give an update on the development of its Global Trade Item Number (GTIN) repository service. Held in collaboration with channel data management and analytics solution provider ValueCentric LLC, the free webinar — titled “Origin: HDA’s Product Data Source” — is scheduled for
